R1 RCM INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.36 USD | +0.57% |
|
+4.39% | -47.67% |
| 04-18 | R1 RCM's Q1 Results to Focus on Strategic Alternatives, Change Cyberattack, RBC Says | MT |
| 04-11 | North American Morning Briefing : Stock Futures -2- | DJ |
Chart calendar R1 RCM Inc.
29fb29.xVQNdzyXpV1R9h1h1Xv2_tdb8YEwadfRraIVlCjzP2k.nGJqTmP7zWU0tXVZhBSFl-4Byct-MZC4-pF6y32-ax2jZ08abMboBxO8XA~02fe33bb8dc0ff5d1f1683ab25c9913a
Upcoming events on R1 RCM Inc.
Past events on R1 RCM Inc.
| 13/03/2024 20:35 | Barclays Global Healthcare Conference |
| 04/03/2024 15:30 | TD Cowen Health Care Conference |
| 27/02/2024 13:00 | Q4 2023 Earnings Call |
| 27/02/2024 12:00 | Q4 2023 Earnings Release |
| 09/01/2024 15:30 | J.P. Morgan Healthcare Conference |
| 06/12/2023 13:00 | Acquisition of Acclara by R1 RCM, Inc Call |
| 29/11/2023 18:20 | Evercore ISI HealthCONx Conference |
| 16/11/2023 16:00 | Stephens Investment Conference |
| 02/11/2023 12:00 | Q3 2023 Earnings Call |
| 02/11/2023 11:00 | Q3 2023 Earnings Release |
| 12/09/2023 20:10 | Baird Global Healthcare Conference |
| 08/08/2023 18:00 | KeyBanc Technology Leadership Forum |
| 02/08/2023 13:00 | Q2 2023 Earnings Call |
| 02/08/2023 12:00 | Q2 2023 Earnings Release |
| 17/05/2023 13:00 | Annual General Meeting |
| 16/05/2023 14:00 | RBC Capital Markets Global Healthcare Conference |
| 10/05/2023 18:00 | Bank of America Securities Healthcare Conference |
| 04/05/2023 13:00 | Q1 2023 Earnings Call |
| 04/05/2023 12:00 | Q1 2023 Earnings Release |
| 16/03/2023 12:00 | Barclays Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 186 1 190 -0.37% | 1 271 1 258 1.05% | 1 475 1 475 -0.02% | 1 806 1 792 0.79% | 2 254 2 255 -0.05% | 2 644 |
|
EBITDA Million USD | Released Forecast Spread | 168 169 -0.69% | 240 234 2.48% | 344 341 0.69% | 426 421 1.04% | 614 609 0.84% | 658 |
|
EBIT Million USD | Released Forecast Spread | 57,7 63,4 -9.06% | 80,0 91,6 -12.71% | 146 141 3.7% | 3,00 -11,8 125.38% | 148 138 7.42% | 112 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 9,80 14,3 -31.57% | 118 73,2 61.8% | 127 121 4.87% | -61,0 -69,1 11.69% | 21,0 10,8 95.07% | -12,4 |
|
Net income Million USD | Released Forecast Spread | -8,70 25,0 -134.74% | 117 52,3 124.02% | 97,2 25,6 279.84% | -57,6 -54,1 -6.41% | 3,30 7,38 -55.3% | -7,08 |
|
EPS USD | Released Forecast Spread | -0,08 0,08 -204.34% | 0,33 0,15 120% | 0,37 -0,90 140.73% | -0,16 -0,14 -17.88% | 0,01 0,02 -59.61% | -0,07 |
| Announcement Date | 20/02/20 | 18/02/21 | 17/02/22 | 16/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 399 399 -0.09% | 386 384 0.39% | 392 392 0.08% | 496 524 -5.29% | 533 519 2.6% | 546 548 -0.48% | 561 562 -0.17% | 573 568 0.78% | 575 577 -0.3% | 611 | 635 | 686 | 711 | 690 |
|
EBITDA Million USD | Released Forecast Spread | 95,1 92,8 2.46% | 89,3 90,5 -1.29% | 87,2 86,1 1.26% | 124 143 -13.27% | 125 121 3.02% | 142 131 8.37% | 143 139 2.44% | 162 157 3.05% | 168 163 2.63% | 148 | 146 | 178 | 187 | 177 |
|
EBIT Million USD | Released Forecast Spread | 50,2 46,1 8.83% | 43,2 42,0 2.79% | -38,0 5,99 -734.53% | 2,00 23,9 -91.63% | -4,20 -19,9 78.89% | 33,7 25,3 33.12% | 23,9 22,8 4.72% | 41,2 41,2 0% | 49,1 41,1 19.46% | 16,7 | 22,7 | 27,9 | 46,9 | 47,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 45,1 39,2 15.03% | 38,5 36,2 6.28% | -44,9 6,54 -786.51% | -21,7 4,75 -556.79% | -32,9 -47,5 30.74% | 3,00 -7,45 140.24% | -8,60 -11,0 21.48% | 9,10 7,25 25.59% | 17,5 7,99 118.89% | -13,9 | -8,72 | 2,44 | 20,7 | 34,2 |
|
Net income Million USD | Released Forecast Spread | 36,0 33,3 8.26% | 29,4 31,5 -6.54% | -20,4 19,2 -206.19% | -29,5 43,9 -167.16% | -37,1 -20,2 -83.75% | 0,30 -6,61 104.54% | 0,30 -2,17 113.85% | 1,30 10,6 -87.74% | 1,40 7,13 -80.35% | -13,3 | -9,29 | 4,42 | 17,4 | 42,4 |
|
EPS USD | Released Forecast Spread | 0,11 0,10 10.09% | 0,09 0,10 -13.89% | -0,07 0,06 -226.56% | -0,07 0,12 -160.22% | -0,09 -0,05 -89.27% | 0,00 -0,02 104.44% | 0,00 0,00 - | 0,00 0,02 - | 0,00 0,02 -83.41% | -0,02 | -0,02 | 0,01 | 0,03 | 0,03 |
| Announcement Date | 17/02/22 | 09/05/22 | 03/08/22 | 08/11/22 | 16/02/23 | 04/05/23 | 02/08/23 | 02/11/23 | 27/02/24 | - | - | - | - | - |
| Today 12:00 | SOTERA HEALTH COMPANY: Q1 2024 Earnings Release |
| Today 21:05 | DAVITA INC.: Q1 2024 Earnings Release |
| 06/05/2024 | INNOVAGE HOLDING CORP.: Q3 2024 Earnings Release |
| 06/05/2024 | FRESENIUS MEDICAL CARE AG: Q1 2024 Earnings Release |
| 07/05/2024 11:00 | PEDIATRIX MEDICAL GROUP, INC.: Q1 2024 Earnings Release |
| 07/05/2024 | RHÖN-KLINIKUM AG: Q1 2024 Earnings Release |
| 07/05/2024 | FRESENIUS SE & CO. KGAA: Q1 2024 Earnings Release |
| 08/05/2024 12:00 | R1 RCM INC.: Q1 2024 Earnings Release |
| 08/05/2024 | SOLVENTUM CORPORATION: Q1 2024 Earnings Release |
| 08/05/2024 | WELL HEALTH TECHNOLOGIES CORP.: Q1 2024 Earnings Release (Projected) |
Past sector events for R1 RCM Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RCM Stock
- RCM Stock
- Calendar R1 RCM Inc.
